India Blocks Exports of Remdesivir and Its Active Pharmaceutical Ingredients
India now prohibits exports of antiviral medication Remdesivir, used to shorten COVID-19 recovery times, along with the drug's active pharmaceutical ingredients, effective with an April 11 trade notice. The products are under Indian Trade Classification Harmonized System Codes Ex 293499…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
and Ex 300490.